Tag: genomics
-
Genome Editing Company Adds $38M in Venture Funds
Crispr Therapeutics, a company creating treatments for disease that edit the human genome, is raising another $38 million in its second venture financing round.
-
Graphene Chip Detects DNA, RNA Mutations
15 June 2016. A biomedical engineering team developed a chip built on graphene that detects mutations in genetic material, for eventual use in mobile diagnostics equipment. Researchers from University of California in San Diego, led by engineering professor Ratnesh Lal, describe their device this week in Proceedings of the National Academy of Sciences. Lal and…
-
Precision Medicine Shown to Boost Cancer Outcomes
7 June 2016. An analysis of results from early-stage clinical trials shows trials using treatments for cancer aimed at specific molecular targets had higher response rates and longer survival times than studies not using these targets. The team from University of California in San Diego, led by postdoctoral researcher Maria Schwaederlé, published its findings in…
-
More Genomic Tests Enhance Personalized Cancer Care
2 June 2016. A pilot study with cancer patients shows comprehensive genomic analyses can provide actionable treatment targets in 9 out of 10 cases, exceeding the performance of commercial diagnostic services available today. A team led by genomics professors Rong Chen and Eric Schadt at Mount Sinai medical school in New York published its findings…
-
Another Chance to Get Serious on Drug Pricing
Stephen Ubl, president and CEO of Pharmaceutical Research and Manufacturers of America, or PhRMA, told a press and industry event in Washington, D.C. on Wednesday (25 May) that drug makers are eager to develop more individualized treatments for patients, but proposed regulations on drug pricing threaten that progress. Ubl also suggested, however, at the Annual…
-
Pricing Factors Proposed for Gene Therapies
Updated 27 May 2016. See Another Chance to Get Serious on Drug Pricing. A pediatric cancer specialist and venture capital executive argue for establishing a framework for pricing gene therapies to treat inherited and other diseases, before these treatments are approved by FDA. Stuart Orkin, a pediatric oncologist and hematologist at Dana-Farber Cancer Research Center…
-
Venture Firm Funding Univ. Blood Diagnostics Technology
23 May 2016. A life sciences venture capital company is funding development of a technology at an Israeli research lab using DNA from blood tests to diagnose a range of diseases. Aurum Ventures is providing $1.2 million to Hebrew University of Jerusalem, through its technology transfer affiliate Yissum Research Development Company, for the university lab…
-
Start-Up Licenses Genetics Technology for HIV Diagnostics
19 May 2016. A spin-off company from Harvard University is licensing genetics research to develop more powerful tools to detect drug-resistant strains of HIV. Financial details of the agreement between the 2 year-old Aldatu Biosciences Inc. and Harvard were not disclosed. Aldatu Biosciences is the creation of pathologist Iain MacLeod and geneticist David Raiser that…
-
Zika Virus Cloned for Drug, Vaccine Development
17 May 2016. Researchers in Texas produced a genetically-engineered clone of the Zika virus to provide a testing platform for developers of diagnostics, vaccines, and treatments for the growing outbreak. The team from University of Texas Medical Branch in Galveston, led by geneticist Pei-Yong Shi, reported its findings yesterday in the journal Cell Host and Microbe.…
-
Portable Genome Device to Combat Wildlife Trafficking
12 May 2016. A handheld device for analyzing DNA can be used on the scene to identify products with endangered wildlife, to help stop poachers and smugglers of those species. A team from University of Leicester in the U.K. that devised this solution is the recipient of a $10,000 prize in the Wildlife Crime Tech…